BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32272196)

  • 1. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
    Dal Moro F; Livi U
    Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
    [No Abstract]   [Full Text] [Related]  

  • 2. The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?
    Dal Moro F; Vendramin I; Livi U
    Med Hypotheses; 2020 Oct; 143():110129. PubMed ID: 32721814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purposing Saikosaponins for the treatment of COVID-19.
    Bahbah EI; Negida A; Nabet MS
    Med Hypotheses; 2020 Jul; 140():109782. PubMed ID: 32353743
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune-Mediated Coagulopathy in COVID-19 Infection.
    Vadasz Z; Brenner B; Toubi E
    Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
    [No Abstract]   [Full Text] [Related]  

  • 5. Proposed use of thalidomide for the cytokine storm of COVID-19.
    Goihman-Yahr M
    Clin Dermatol; 2020; 38(4):508. PubMed ID: 32972614
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxytocin as a potential defence against Covid-19?
    Soumier A; Sirigu A
    Med Hypotheses; 2020 Jul; 140():109785. PubMed ID: 32344303
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations for Statin Therapy in Patients with COVID-19.
    Dashti-Khavidaki S; Khalili H
    Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
    [No Abstract]   [Full Text] [Related]  

  • 8. Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
    Severa M; Farina C; Salvetti M; Coccia EM
    Front Immunol; 2020; 11():1459. PubMed ID: 32655578
    [No Abstract]   [Full Text] [Related]  

  • 9. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
    Cadegiani FA
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
    [No Abstract]   [Full Text] [Related]  

  • 10. The broad-spectrum antiviral recommendations for drug discovery against COVID-19.
    Hazafa A; Ur-Rahman K; Haq IU; Jahan N; Mumtaz M; Farman M; Naeem H; Abbas F; Naeem M; Sadiqa S; Bano S
    Drug Metab Rev; 2020 Aug; 52(3):408-424. PubMed ID: 32546018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S; Saulnier A; Gatignol A
    Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
    [No Abstract]   [Full Text] [Related]  

  • 13. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
    Kalil AC
    JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
    [No Abstract]   [Full Text] [Related]  

  • 16. Audio Interview: Tocilizumab and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral Methioninase for Covid-19 Methionine-restriction Therapy.
    Hoffman RM; Han Q
    In Vivo; 2020 Jun; 34(3 Suppl):1593-1596. PubMed ID: 32503816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.
    Sodhi M; Etminan M
    Pharmacotherapy; 2020 May; 40(5):487-488. PubMed ID: 32267566
    [No Abstract]   [Full Text] [Related]  

  • 19. Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.
    Bou Khalil R
    Med Hypotheses; 2020 Sep; 142():109798. PubMed ID: 32413699
    [No Abstract]   [Full Text] [Related]  

  • 20. Colchicine may not be effective in COVID-19 infection; it may even be harmful?
    Cumhur Cure M; Kucuk A; Cure E
    Clin Rheumatol; 2020 Jul; 39(7):2101-2102. PubMed ID: 32394215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.